Your AI-Trained Oncology Knowledge Connection!

Integrating Molecular Testing into Decision Making in NSCLC : Episode 10

Video

November 9, 2022

The Future of Molecular Testing in NSCLC

Author(s):

Benjamin Levy, MD,Bhuvana Ramkumar, MD

The panel closes by highlighting unmet needs in molecular testing, and advances they are looking forward to.

EP: 1.Challenges With and Strategies for Tissue Procurement in NSCLC

EP: 2.Enhancing Communication Among the Multidisciplinary Care Team

EP: 3.Best Practices for Accurate Tissue Genotyping in NSCLC

EP: 4.Average Turnaround Time for NSCLC Molecular Testing

EP: 5.Types of Tissue Next-Generation Sequencing Platforms in NSCLC

EP: 6.Using Liquid Biopsy for Molecular Testing in NSCLC

EP: 7.Integrating Molecular Testing Results into Electronic Medical Records

EP: 8.Receiving Molecular Testing Results for NSCLC

EP: 9.Financial Considerations with Molecular Testing for Patients With NSCLC

Now Viewing

EP: 10.The Future of Molecular Testing in NSCLC

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Multimedia

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

May 15th 2025 - May 16th 2026

online-activity

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

May 15th 2025 - May 16th 2026

online-activity

Video

(CME Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

May 15th 2025 - May 16th 2026

online-activity

Latest Conference Coverage

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

Zanidatamab/Chemotherapy Yields Responses and Is Safe in HER2-Expressing Metastatic Breast Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

The Future of Molecular Testing in NSCLC

EP: 1.Challenges With and Strategies for Tissue Procurement in NSCLC

EP: 2.Enhancing Communication Among the Multidisciplinary Care Team

EP: 3.Best Practices for Accurate Tissue Genotyping in NSCLC

EP: 4.Average Turnaround Time for NSCLC Molecular Testing

EP: 5.Types of Tissue Next-Generation Sequencing Platforms in NSCLC

EP: 6.Using Liquid Biopsy for Molecular Testing in NSCLC

EP: 7.Integrating Molecular Testing Results into Electronic Medical Records

EP: 8.Receiving Molecular Testing Results for NSCLC

EP: 9.Financial Considerations with Molecular Testing for Patients With NSCLC

EP: 10.The Future of Molecular Testing in NSCLC

Newsletter

Latest CME

(CME Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Indiana

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

(CME Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Indiana

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

(CME Track) Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Community Oncology Connections™: Contextualizing Novel Immunotherapy for Advanced Melanoma – How Do TIL Therapies Fit into Practice? | Indiana

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

Latest Conference Coverage